Cloutier J F, Veillette A
McGill Cancer Centre, McGill University, Montréal, Québec, Canada H3G 1Y6.
J Exp Med. 1999 Jan 4;189(1):111-21. doi: 10.1084/jem.189.1.111.
Antigen receptor-triggered T-cell activation is mediated by the sequential action of the Src and Syk/Zap-70 families of protein tyrosine kinases (PTKs). Previously, we reported that another PTK termed p50(csk) was a potent negative regulator of T-cell receptor (TCR) signaling because of its ability to inactivate Src-related kinases. This inhibitory effect required the catalytic activity of Csk, as well as its Src homology (SH)3 and SH2 domains. Subsequent studies uncovered that, via its SH3 domain, p50(csk) was associated with PEP, a proline-enriched protein tyrosine phosphatase (PTP) of unknown function expressed in hemopoietic cells. Herein, we have attempted to identify the role of the Csk-PEP complex in T lymphocytes. The results of our experiments showed that, like Csk, PEP was a strong repressor of TCR signaling. This property was dependent on the phosphatase activity of PEP, as well as on the sequence mediating its binding to p50(csk). Through reconstitution experiments in Cos-1 cells, evidence was obtained that Csk and PEP act synergistically to inhibit protein tyrosine phosphorylation by Src-related kinases, and that this effect requires their association. Finally, experiments with a substrate-trapping mutant of PEP suggested that PEP functions by dephosphorylating and inactivating the PTKs responsible for T-cell activation. In addition to giving novel insights into the mechanisms involved in the negative regulation of T-cell activation, these findings indicate that the association of an inhibitory PTK with a PTP constitutes a more efficient means of inhibiting signal transduction by Src family kinases in vivo.
抗原受体触发的T细胞活化是由Src和Syk/Zap-70家族的蛋白酪氨酸激酶(PTK)的顺序作用介导的。先前,我们报道另一种称为p50(csk)的PTK是T细胞受体(TCR)信号的有效负调节因子,因为它具有使Src相关激酶失活的能力。这种抑制作用需要Csk的催化活性及其Src同源性(SH)3和SH2结构域。随后的研究发现,通过其SH3结构域,p50(csk)与PEP相关联,PEP是一种在造血细胞中表达的功能未知的富含脯氨酸的蛋白酪氨酸磷酸酶(PTP)。在此,我们试图确定Csk-PEP复合物在T淋巴细胞中的作用。我们的实验结果表明,与Csk一样,PEP是TCR信号的强抑制剂。这种特性取决于PEP的磷酸酶活性以及介导其与p50(csk)结合的序列。通过在Cos-1细胞中的重组实验,获得的证据表明Csk和PEP协同作用以抑制Src相关激酶的蛋白酪氨酸磷酸化,并且这种作用需要它们的结合。最后,用PEP的底物捕获突变体进行的实验表明,PEP通过使负责T细胞活化的PTK去磷酸化并使其失活来发挥作用。除了对T细胞活化的负调节机制提供新的见解外,这些发现还表明抑制性PTK与PTP的结合构成了体内抑制Src家族激酶信号转导的更有效手段。